Research Groups
MOPSY – Multidisciplinary Psychosocial Cancer Research Group
Anssi Auvinen – Cancer Epidemiology, Prostate Cancer Screening
G Steven Bova – PELICAN, Personalized Cancer Medicine
Kirsi Rautajoki – Cancer Regulation and Immunology
Mikko Hurme – Microbiology and Immunology
Vesa Hytönen – Protein Dynamics
Teemu Ihalainen – Cellular Biophysics
Arja Jukkola – Radiotherapy and oncology
Meenakshi Kandhavelu – Molecular Signaling Lab
Xin Lai – Lailab
Johanna Laukkarinen – Tampere Pancreas Group
Terho Lehtimäki – Clinical Chemistry
Matti Lehtinen – HPV Vaccination Research
Olli Lohi – Hematology and Oncology
Teemu Murtola – Pharmacoepidemiology and Chemoprevention of Urological Cancers
Matti Nykter – Computational Biology
Niku Oksala – Surgery (especially Vascular Surgery)
Seppo Parkkila – Anatomy and Tissue Biology
Ilkka Pietilä – QPro3 (MOPSY)
Pekka Ruusuvuori – Bioimage Informatics
Olli Silvennoinen – Medical Biochemistry
Alfonso Urbanucci – Genomic Regulation for Precision Cancer Medicine
Toni Seppälä – Precision Medicine in Abdominal Cancers
Tapio Visakorpi – Molecular Biology of Prostate Cancer
Minni Änkö – Functional RNAomics
Research centers
Center for Cancer Eradication Research (CCER)
Research center combining diverse people, skills, methods and data from multiple cancer research groups into collaboration to produce top-level cancer research for the benefit of patients and the society
TamCAM – Tampere Center for Child, Adolescent and Maternal Health Research
Tampere Center for Child, Adolescent and Maternal Health Research (TamCAM) is a population-group based research center formed around multidisciplinary research groups that strive to advance the health and wellbeing of human beings from the womb to adulthood.
FONK
FONK is a cancer medication research unit for adults that operates at the Tampere Univeristy Hospital. The objectives of the unit are to improve the research possibilities of new cancer medication and to introduce new medication to patient use as early as possible.
PeeTU
Paediatric Clinical Trials Unit (PeeTU) operates at the Tampere Univeristy Hospital. It offers centralised clinical trial services (phase I-II) to children and adolescents in Finland. The major goal is to provide access to early phase clinical trials for children with relapsed or refractory cancers, but we also aim to find novel agents to treat various other conditions.